ARCHIVES

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding

September 18, 1992

In Brief: Money Bill Awaits President’s Decisions; M.D. Anderson To Dedicate New Faculties

September 24, 1976

Cooperative Group Chairman Blast Cut In’81 Budget

February 15, 1980

Siemens To Provide Technology To DxTx For Lung Cancer Detection.

December 14, 2001

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014